Cg Oncology Inc (NASDAQ: CGON) on Tuesday, plunged -3.31% from the previous trading day, before settling in for the closing price of $26.9. Within the past 52 weeks, CGON’s price has moved between $14.80 and $40.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -31.97%. With a float of $44.88 million, this company’s outstanding shares have now reached $76.22 million.
Considering the fact that the conglomerate employs 113 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 98.94%, operating margin of -20302.27%, and the pretax margin is -15945.17%.
Cg Oncology Inc (CGON) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cg Oncology Inc is 41.12%, while institutional ownership is 67.97%. The most recent insider transaction that took place on Jul 17 ’25, was worth 56,000. In this transaction Director of this company sold 2,000 shares at a rate of $28.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Jul 17 ’25, when Company’s Director proposed sale 2,000 for $26.08, making the entire transaction worth $52,160.
Cg Oncology Inc (CGON) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -31.97% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Cg Oncology Inc (CGON) is currently performing well based on its current performance indicators. A quick ratio of 30.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3003.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.80 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Compared to the last year’s volume of 1.02 million, its volume of 1.37 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 44.13%.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 64.06%, which indicates a significant increase from 33.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.43 in the past 14 days, which was lower than the 1.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.06, while its 200-day Moving Average is $28.66. Nevertheless, the first resistance level for the watch stands at $27.02 in the near term. At $28.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $29.30. If the price goes on to break the first support level at $24.75, it is likely to go to the next support level at $23.49. Should the price break the second support level, the third support level stands at $22.47.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
Market capitalization of the company is 1.98 billion based on 76,225K outstanding shares. Right now, sales total 1,140 K and income totals -88,040 K. The company made 50 K in profit during its latest quarter, and -34,450 K in sales during its previous quarter.
